Immune response and protective efficacy against homologous challenge in BALB/c mice vaccinated with DNA vaccine encoding Toxoplasma gondii actin depolymerizing factor gene

Veterinary Parasitology

Volumn 179, Issue 1-3, 2011, Pages 1-6

  Li, Jianhua ^a   Huang, Xiangsheng ^a   Zhang, Guocai ^a   Gong, Pengtao ^a   Zhang, Xichen ^a   Wu, Ling ^a  

^a JILIN UNIVERSITY   (China)

Author keywords

Actin depolymerizing factor; BALB c mice; DNA vaccine; Toxoplasma gondii

Indexed keywords

ACTIN DEPOLYMERIZING FACTOR; DNA VACCINE; MICROORGANISM PROTEIN; PROTEIN VAX1; UNCLASSIFIED DRUG;

ACTIN DEPOLYMERIZING FACTOR GENE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; BAGG ALBINO MOUSE; BRAIN CYST; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG EFFICACY; HUMORAL IMMUNITY; INFECTION PREVENTION; MALE; MOUSE; NONHUMAN; SURVIVAL TIME; TOXOPLASMA GONDII; TOXOPLASMOSIS;

ACTIN DEPOLYMERIZING FACTORS; ANIMALS; FEMALE; HELA CELLS; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; MICE; MICE, INBRED BALB C; PROTOZOAN VACCINES; TOXOPLASMA; TOXOPLASMOSIS, ANIMAL; VACCINES, DNA;

MUS; TOXOPLASMA GONDII;

EID: 79957618778     PISSN: 03044017     EISSN: 18732550     Source Type: Journal    
DOI: 10.1016/j.vetpar.2011.03.003     Document Type: Article

References (40)

1. Allen M.L., Dobrowolski J.M., Muller H., Sibley L.D., Mansour T.E. Cloning and characterization of actin depolymerizing factor from Toxoplasma gondii. Mol. Biochem. Parasitol. 1997, 88:43-52.
2. Angus C.W., Klivington-Evans D., Dubey J.P., Kovacs J.A. Immunization with a DNA plasmid encoding the SAG1 (SAG1) protein of Toxoplasma gondii is immunogenic and protective in rodents. J. Infect. Dis. 2000, 181:317-324.
3. Beghetto E., Nielsen H.V., Del Porto P., Buffolano W., Guglietta S., Felici F., Petersen E., Gargano N. A combination of antigenic regions of Toxoplasma gondii microneme proteins induces protective immunity against oral infection with parasite cysts. J. Infect. Dis. 2005, 191:637-645.
4. Bhopale G.M. Development of a vaccine for toxoplasmosis: current status. Microb. Infect. 2003, 5:457-462.
5. Black M.W., Boothroyd J.C. Lytic cycle of Toxoplasma gondii. Microbiol. Mol. Biol. Rev. 2000, 64:607-623.
6. Bout D.T., Mevelec M.N., Velge-Roussel F., Dimier-Poisson I., Lebrun M. Prospects for a human Toxoplasma vaccine. Curr. Drug Targets Immune Endocr. Metabol. Disord. 2002, 2:227-234.
7. Cong H., Gu Q.M., Yin H.E., Wang J.W., Zhao Q.L., Zhou H.Y., Li Y., Zhang J.Q. Multi-epitope DNA vaccine linked to the A2/B subunit of cholera toxin protect mice against Toxoplasma gondii. Vaccine 2008, 26:3913-3921.
8. Couper K.N., Nielsen H.V., Petersen E., Roberts F., Roberts C.W., Alexander J. DNA vaccination with the immunodominant tachyzoite surface antigen (SAG-1) protects against adult acquired Toxoplasma gondii infection but does not prevent maternofoetal transmission. Vaccine 2003, 21:2813-2820.
9. Dautu G., Munyaka B., Carmen G., Zhang G., Omata Y., Xuenan X., Igarashi M. Toxoplasma gondii: DNA vaccination with genes encoding antigens MIC2, M2AP, AMA1 and BAG1 and evaluation of their immunogenic potential. Exp. Parasitol. 2007, 116:273-282.
10. Denkers E.Y., Gazzinelli R.T. Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection. Clin. Microbiol. Rev. 1998, 11:569-588.
11. Dobrowolski J.M., Sibley L.D. The role of the cytoskeleton in host cell invasion by Toxoplasma gondii. Behring Inst. Mitt. 1997, 99:90-96.
12. Dubey J.P. Status of toxoplasmosis in sheep and goats in the United States. J. Am. Vet. Med. A 1990, 196:259-262.
13. Fachado A., Rodriguez A., Angel S.O., Pinto D.C., Vila I., Acosta A., Amendoeira R.R., Lannes-Vieira J. Protective effect of a naked DNA vaccine cocktail against lethal toxoplasmosis in mice. Vaccine 2003, 21:1327-1335.
14. Fang R., Nie H., Wang Z.S., Tu P., Zhou D., Wang L.X., He L., Zhou Y., Zhao J. Protective immune response in BALB/c mice induced by a suicidal DNA vaccine of the MIC3 gene of Toxoplasma gondii. Vet. Parasitol. 2009, 164:134-140.
15. Fang R., Feng H., Nie H., Wang L., Tu P., Song Q., Zhou Y., Zhao J. Construction and immunogenicity of pseudotype baculovirus expressing Toxoplasma gondii SAG1 protein in BALB/c mice model. Vaccine 2010, 28:1803-1807.
16. Fowler R.E., Margos G., Mitchell G.H. The cytoskeleton and motility in apicomplexan invasion. Adv. Parasitol. 2004, 56:213-263.
17. + T lymphocytes in IFN-γ production and protective immunity induced by an attenuated Toxoplasma gondii vaccine. J. Immunol. 1991, 146:286-292.
18. + T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii. J. Immunol. 1992, 149:175-180.
19. Guo H., Liu Z., Sun S., Bao H., Chen Y., Liu X., Xie Q. Immune response in guinea pigs vaccinated with DNA vaccine of foot-and mouth disease virus O/China 99. Vaccine 2005, 23:3236-3242.
20. Hu K., Johnson J., Florens L., Fraunholz M., Suravajjala S., DiLullo C., Yates J., Roos D.S., Murray J.M. Cytoskeletal components of an invasion machine the apical complex of Toxoplasma gondii. PLoS Pathogens 2006, 2:e13.
21. Ismael A.B., Sekkai D., Collin C., Bout D., Mévélec M.N. The MIC3 gene of Toxoplasma gondii is a novel potent vaccine candidate against toxoplasmosis. Infect. Immun. 2003, 71:6222-6228.
22. Jongert E., de Craeye S., Dewit J., Huygen K. GRA7 provides protective immunity in cocktail DNA vaccines against Toxoplasma gondii. Parasite. Immunol. 2007, 29:445-453.
23. Leyva R., Hérion P., Saavedra R. Genetic immunization with plasmid DNA coding for the ROP2 protein of Toxoplasma gondii. Parasitol. Res. 2001, 87:70-79.
24. Liu S., Shi L., Cheng Y.B., Fan G.X., Ren H.X., Yuan Y.K. Evaluation of protective effect of multi-epitope DNA vaccine encoding six antigen segments of Toxoplasma gondii in mice. Parasitol. Res. 2009, 105:267-274.
25. Liu Q., Gao S.Y., Jiang L., Shang L.M., Men J.T., Wang Z., Zhai Y.J., Xia Z.P., Hu R.L., Zhang X.C., Zhu X.Q. A recombinant Pseudorabies virus expressing TgSAG1 protects against challenge with the virulent Toxoplasma gondii RH strain and pseudorabies in BALB/c mice. Microb. Infect. 2008, 8:1-8.
26. Maciver S.K., Hussey P.J. The ADF/cofilin family: actin-remodeling proteins. Genome Biol. 2002, 3:3007.
27. Mateus-Pinilla N.E., Dubey J.P., Choromanski L., Weigel R.M. A field trial of the effectiveness of a feline Toxoplasma gondii vaccine in reducing T. gondii exposure for swine. J. Parasitol. 1999, 85:855-860.
28. Morrissette N.S., Sibley L.D. Cytoskeleton of apicomplexan parasites. Microbiol. Mol. Biol. Rev. 2002, 66:21-38.
29. Saavedra R., Becerril M.A., Dubeaux C.R., Lippens M.D., Herion V.P., Bollen A. Epitopes recognized by human T lymphocytes in the RoP2 protein antigen of Toxoplasma gondii. Infect. Immun. 1996, 64:3858-3862.
30. Sher A., Colley D.G. Immunoparasitology. Fundamental Immunology 1989, 1989:957-983. Raven Press, New York. 2nd edition.
31. Sibley L.D. Intracellular parasite invasion strategies. Science 2004, 304:248-253.
32. Suzui Y., Conley F.K., Remington J.S. Importance of endogenous IFN-for prevention of toxoplasmic encephalitis in mice. J. Immunol. 1989, 143:2045.
33. + T cells in mice. J. Immunol. 1988, 140:3943.
34. Suzuki Y., Orellana M.A., Schreiber R.D., Remington J.S. Interferon-γ: the major mediator of resistance against T. gondii. Science 1988, 240:516.
35. Vercammen M., Scorza T., Huygen K., De Braekeleer J., Diet R., Jacobs D., Saman E., Verschueren H. DNA vaccination with genes encoding Toxoplasma gondii antigens GRA1. GRA7, and ROP2 induces partially protective immunity against lethal challenge in mice. Infect. Immun. 2000, 68:38-45.
36. Wang H., Liu Q., Liu K., Zhong W., Gao S., Jiang L., An N. Immune response induced by recombinant Mycobacterium bovis BCG expressing ROP2 gene of Toxoplasma gondii. Parasitol. Int. 2007, 56:263-268.
37. Wang H., He S., Yao Y., Cong H., Zhao H., Li T., Zhu X.Q. Toxoplasma gondii: protective effect of an intranasal SAG1 and MIC4 DNA vaccine in mice. Exp. Parasitol. 2009, 122:226-232.
38. Xiao S.B., Chen H.C., Fang L.R., Liu C.S., Zhang H., Jiang Y.B. Comparison of immune responses and protective efficacy of suicidal DNA vaccine and conventional DNA vaccine encoding glycoprotein C of Pseudorabies virus in mice. Vaccine 2004, 22:345-351.
39. Xue M., He S., Cui Y., Yao Y., Wang H. Evaluation of the immune response elicited by multi-antigenic DNA vaccine expressing SAG1 ROP2 and GRA2 against Toxoplasma gondii. Parasitol. Int. 2008, 57:424-429.
40. Zhang J., He S., Jiang H., Yang T., Cong H., Zhou H., Zhang J., Gu Q., Li Y., Zhao Q. Evaluation of the immune response induced by multiantigenic DNA vaccine encoding SAGl and ROP2 of Toxoplasma gondii and the adjuvant properties of murine interleukin-12 plasmid in BALB/c mice. Parasitol. Res. 2007, 101:331-338.